SYNTHESIS AND ANTICONVULSANT ACTIVITY OF SOME ,3,3A-TETRAHYDROPYRROLO[2,1-B]-BENZOTHIAZOL-1-ONE, 1,2,3,3A-TETRAHYDROPYRROLO[2,1-B]-THIAZOL-1-ONE OR 1,2,3,3A-TETRAHYDROPYRROLO[2,1-B]-OXAZOL-1-ONE IN RODENTS
G. Trapani et al., SYNTHESIS AND ANTICONVULSANT ACTIVITY OF SOME ,3,3A-TETRAHYDROPYRROLO[2,1-B]-BENZOTHIAZOL-1-ONE, 1,2,3,3A-TETRAHYDROPYRROLO[2,1-B]-THIAZOL-1-ONE OR 1,2,3,3A-TETRAHYDROPYRROLO[2,1-B]-OXAZOL-1-ONE IN RODENTS, Journal of Pharmacy and Pharmacology, 48(8), 1996, pp. 834-840
To identify more potent anticonvulsant agents and to gain insights int
o the structural properties determining the potency of a new class of
anticonvulsants, some 3a-substituted tetrahydropyrrolo[2,1-b]benzothia
zol-1-ones (1a-d) and the thiazole and oxazole analogues (2a-c and 3a-
c, respectively) have been synthesized and tested for anticonvulsant a
ctivity against isoniazid-induced seizures in rodents. The most active
compound, 2a, with a median effective dose (ED50, i.p.) of 24.3 mg kg
(-1) and 15.9 mg kg(-1) in mice and in rats, respectively, was more ex
tensively investigated and found to strengthen the effects of diazepam
. No clear correlation was observed between the anticonvulsant activit
y and molecular lipophilicity descriptors of compounds 1-3. Structural
similarity between the antiepileptic drug phenobarbital and compounds
1-3 was evidenced by molecular modelling studies and used to derive p
reliminary structure-activity relationships. The results demonstrate t
hat 2a is an attractive candidate as an anticonvulsant agent worthy of
further study and may help the design of other anticonvulsant drugs.